who owns the patent for semaglutide Ozempic just got much, much cheaper in India. On March 21, Danish company Novo Nordisk's on semaglutide, active ingredient behind its diabetes and weight-loss drugs Ozempic and Wegovy, expired in Massive Rs 50,000 Cr Opportunity
Pay in 4 interest-free payments of $5.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31






:max_bytes(150000):strip_icc()/GettyImages-1472399442-33242d042c8c4776b4ac9e2133de7b59.jpg)















